arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Allogene Therapeutics, Inc.

ALLO

$2.01 ▲ +0.04 (+2.29%) at close

34 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Allogene Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $483.0M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -13.1% ↘

FCF / Share $-0.05

Trailing P/E —

Price / Book 1.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

34-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-42.61M

↑ +28.7% —

Operating Margin Operating profit as % of sales

2.3%

↑ +102.6% —

FCF / Share Free cash flow per share

$-0.05

↑ +78.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2017

$0.00

FY 2018

$0.00

FY 2019

$0.00

FY 2020

$0.00

FY 2021

$0.00

FY 2022

$0.00

FY 2023

$0.00

FY 2024

$0.00

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	N/M	N/M	N/M	N/M	-57.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-821%)	N/M	-12.2% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-253%)	-48.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-710%)	-14.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-284%)	N/M	0.0% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	95.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1093%)	-99.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1348%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	35.7% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	39.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	40.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	34.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	26.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	45.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	13.5% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	34.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	44.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	28.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	36.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-1.9% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-21.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-1.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	1.9% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	28.7% Excellent ↑ Excellent Improving Year-over-year change in net income	35.3% Excellent ↑ Excellent Improving Year-over-year change in net income	8.1% Fair ↓ Fair Declining Year-over-year change in net income	8.1% Fair ↓ Fair Declining Year-over-year change in net income	8.1% Fair ↓ Fair Declining Year-over-year change in net income	30.1% Excellent ↓ Excellent Declining Year-over-year change in net income	34.1% Excellent ↑ Excellent Improving Year-over-year change in net income	34.1% Excellent ↑ Excellent Improving Year-over-year change in net income	34.1% Excellent ↑ Excellent Improving Year-over-year change in net income	16.4% Good ↑ Good Improving Year-over-year change in net income	-23.6% Weak ↑ Weak Improving Year-over-year change in net income	-32.0% Weak ↓ Weak Declining Year-over-year change in net income	-23.6% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-2.1% Weak ↑ Weak Improving Year-over-year change in net income	-5.4% Weak ↑ Weak Improving Year-over-year change in net income	-141.9% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-18.1% Weak ↓ Weak Declining Year-over-year change in net income	-16.3% Weak ↓ Weak Declining Year-over-year change in net income	39.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-12.4% Weak ↓ Weak Declining Year-over-year change in net income	-30.5% Weak ↓ Weak Declining Year-over-year change in net income	-47.8% Weak ↓ Weak Declining Year-over-year change in net income	77.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-100.0% Weak ↑ Weak Improving Year-over-year change in net income	-16.6% Weak ↑ Weak Improving Year-over-year change in net income	69.4% Excellent Excellent Year-over-year change in net income	-9260.8% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	78.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	25.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	29.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	5.7% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	-91.7% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-85%)	—	—	-86.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-677%)	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-99%)	—	—	-86.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-817%)	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-61.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-145.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	-536.88x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.69x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.17x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.05x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-13.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-12.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-11.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-11.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	0.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	10.4% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	104.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	79.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-11.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-12.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-11.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-11.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	0.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-5.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-7.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-5.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-15.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-13.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-18.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-226%)	-17.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-216%)	-15.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	-14.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-14.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-12.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-14.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-16.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-212%)	-16.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	-15.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	-16.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-13.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-10.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-9.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-9.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	0.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-100%)	-8.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-6.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-3.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-121%)	-6.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	-5.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-5.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-9.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-9.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-8.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-6.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	-35.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-338%)	-4.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	25.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+72%)	104.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+595%)	100.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+567%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-6.61x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-30.31M	$-51.69M	$-37.81M	$-52.33M	$-42.45M	$-75.22M	$-51.24M	$-170.67M	$-51.04M	$-83.16M	$-69.25M	$-154.76M	$-109.93M	$-74.36M	$-74.36M	$-96.04M	$-84.51M	$-84.51M	$-190.02M	$-223.50M	$-236.87M	—	$-158.14M	$-280.38M	$-135.90M	—	$-160.99M	$-112.58M	$-92.75M	—	$-83.14M	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	—	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.18	$-0.17	$-0.19	$-0.23	$-0.28	$-0.28	$-0.32	$-0.35	$-0.38	$-0.51	$-0.37	$-0.53	$-0.68	$-0.71	$-0.58	$-0.52	$-0.56	$0.01	$-0.57	$-0.53	—	$-0.53	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.05	—	$-0.13	$-0.18	$-0.25	—	—	—	$-0.33	—	—	—	$-0.47	—	—	—	$-0.50	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.14	$1.28	$1.41	$1.57	$1.76	$1.99	$2.21	$2.46	$2.71	$3.04	$3.47	$3.73	$4.06	$5.16	$5.14	$5.58	$5.96	$6.44	$6.81	$7.20	$7.56	—	$8.00	$8.36	$4.84	—	$5.08	$5.39	$5.61	—	$-5.39	—	—	$0.00
Tangible Book Value per Share (USD)	$1.14	$1.28	$1.41	$1.57	$1.76	$1.99	$2.21	$2.46	$2.71	$3.04	$3.47	$3.73	$4.06	$5.16	$5.14	$5.58	$5.96	$6.44	$6.81	$7.20	$7.56	—	$8.00	$8.36	$4.84	—	$5.08	$5.39	$5.60	—	$-5.42	—	—	$0.00
Basic Weighted Avg Shares (shares)	240.29M	—	222.04M	218.93M	215.36M	—	209.19M	190.03M	169.13M	—	167.65M	146.80M	144.56M	—	143.66M	143.39M	141.36M	—	137.03M	134.83M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$244.96M	$225.24M	$228.89M	$250.98M	$261.55M	$267.86M	$271.84M	$419.82M	$364.47M	$422.04M	$435.82M	$447.38M	$421.88M	$520.98M	$520.19M	$468.12M	$432.87M	$433.13M	$449.37M	$556.17M	$661.21M	—	$803.93M	$868.68M	$477.60M	—	$476.40M	$473.54M	$449.36M	—	$87.88M	—	—	—
Total Equity (USD)	$278.88M	$292.54M	$315.33M	$344.56M	$385.39M	$422.18M	$463.75M	$515.04M	$461.37M	$512.23M	$583.10M	$622.91M	$592.26M	$743.40M	$739.96M	$801.95M	$855.23M	$925.20M	$969.94M	$1.02B	$1.07B	$1.08B	$1.12B	$1.16B	$606.52M	$629.02M	$619.72M	$655.63M	$681.23M	$703.16M	$-168.44M	$-129.44M	$-2.59M	$0.00

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	—	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$22.00K	$21.00K	$43.00K	$44.00K	$52.00K	$-40.00K	$49.00K	$86.00K	$61.00K	$75.65M	$49.00K	$44.00K	$38.34M	$0.00	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$2.87M	$3.06M	$3.10M	$3.11M	$3.10M	$3.23M	—	—	$3.56M	$3.48M	$3.57M	$3.64M	$3.51M	$3.07M	—	—	$3.69M	$4.24M	—	—	$1.92M	$1.84M	—	—	$1.89M	$1.70M	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-42.61M	$-38.81M	$-59.73M	$-59.73M	$-59.73M	$-59.94M	$-65.00M	$-65.00M	$-65.00M	$-85.78M	$-98.70M	$-98.70M	$-98.70M	$-102.63M	$-79.85M	$-74.79M	$-79.85M	$86.00K	$-78.19M	$-70.94M	$-33.02M	$-68.57M	$-66.20M	$-60.97M	$-54.48M	$-61.03M	$-50.73M	$-41.24M	$-243.10M	$-30.51M	$-43.50M	$-134.90M	$-2.60M	—
Operating Cash Flow (USD)	$-12.91M	$-27.60M	$-29.69M	$-39.03M	$-52.93M	$-36.70M	—	—	$-55.90M	$-53.71M	—	—	$-66.64M	$-62.10M	—	—	$-68.24M	$-45.44M	—	—	$-49.33M	$-9.97M	—	—	$-40.81M	$-50.27M	—	—	$-30.26M	$-21.48M	—	$-6.05M	$5.00K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 34 quarters

Allogene Therapeutics, Inc.

Analytical Summary

34-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ALLO with peers